Ayala Pharmaceuticals Inc (ADXS)

[ignatiusrielly35]

That is exactly my view. Since there is no justifiable reason whatsoever for the current low share price, there is nothing "bad" that needs to be attributed to anyone in the first place. Raising working capital is not a mistake, and neither is it a reason to severely adjust a company's valuation. It comes as a surprise to analysts and the street? This is a clinical biotech with a dozen irons in the fire, for cripes sake.